StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Kiora Pharmaceuticals's pe ratio was 2.7× on Apr 30, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20252.7×+0.9
2024Dec 31, 20241.8×–

More Kiora Pharmaceuticals figures

See a number that looks wrong?